Tsumura & Co. (TYO:4540)

Japan · Delayed Price · Currency is JPY

3,703.00

-46.00 (-1.23%)

Oct 2, 2026, 3:30 PM JST

Market Cap	276.04B +4.3%
Revenue (ttm)	199.23B +10.4%
Net Income	30.21B +17.9%
EPS	405.00 +19.7%
Shares Out	74.55M
PE Ratio	9.14
Forward PE	10.30
Dividend	158.00 (4.27%)
Ex-Dividend Date	Sep 29, 2026

Volume	353,100
Open	3,735.00
Previous Close	3,749.00
Day's Range	3,693.00 - 3,735.00
52-Week Range	3,444.00 - 4,403.00
Beta	0.04
Analysts	Hold
Price Target	4,314.00 (+16.5%)
Earnings Date	Nov 9, 2026

About Tsumura & Co.

Tsumura & Co. engages in the production and sale of Kampo extract intermediates and granular Kampo formulations in Japan and internationally. The company offers products for female problems, proneness to fatigue, skin problems, gastrointestinal problems, obesity, constipation and hemorrhoids, as well as body aches, children's sickness, stress, urinary problems, and cold, cough, and nasal/throat inflammation symptoms. It is also involved in manufacturing and sales of prescription drugs and over-the-counter Kampo medicines. In addition, it produc... [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 1893

Employees 4,923

Stock Exchange Tokyo Stock Exchange

Ticker Symbol 4540

Full Company Profile

Financial Performance

In fiscal year 2026, Tsumura & Co.'s revenue was 192.62 billion, an increase of 6.36% compared to the previous year's 181.09 billion. Earnings were 28.12 billion, a decrease of -13.29%.

Financial Statements

Analyst Summary

According to 5 analysts, the average rating for 4540 stock is "Hold." The 12-month stock price target is ¥4,314, which is an increase of 16.50% from the latest price.

Price Target

¥4,314

(16.50% upside)

Analyst Consensus: Hold

Stock Forecasts